Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-066963
Filing Date
2014-11-12
Accepted
2014-11-12 11:08:40
Documents
1
Period of Report
2014-11-10

Document Format Files

Seq Description Document Type Size
1 form471358_20141112110709-.html 4  
1 form471358_20141112110709-.xml 4 3136
  Complete submission text file 0001144204-14-066963.txt   4631
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address
Rowinsky Eric K (Reporting) CIK: 0001318886 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 141212202